Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
November 21, 2017International Journal of CancerOpen Access

Administration of adjuvant chemotherapy for stageII‐IIIcolon cancer patients: An European population‐based study

View Full Paper
Ask AI
Bookmark
Share

Authors

MBMasoud BabaeiTehran University of Medical SciencesYBYesilda BalavarcaOslo University HospitalLJLina JansenGerman Cancer Research Center

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Babaei et al. (2017) studied this question.

synapsesocial.com/papers/6a5eef333b1677c8bf068253https://doi.org/10.1002/ijc.31168
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Characteristics of patients with stage III colon adenocarcinoma who fail to receive guideline‐recommended treatment2010 · 63 citations
  2. 2Adjuvant Therapy With Fluorouracil and Oxaliplatin in Stage II and Elderly Patients (between ages 70 and 75 years) With Colon Cancer: Subgroup Analyses of the Multicenter International Study of Oxaliplatin, Fluorouracil, and Leucovorin in the Adjuvant Treatment of Colon Cancer Trial2012 · 390 citations
  3. 3Completion of Therapy by Medicare Patients With Stage III Colon Cancer2006 · 148 citations
  4. 4Minimally Invasive Colorectal Cancer Surgery in Europe2016 · 26 citations
  5. 5Risk of recurrence in patients with colon cancer stage II and III: A systematic review and meta-analysis of recent literature2014 · 376 citations